Chemed
522 hedge funds and large institutions have $6.15B invested in Chemed in 2025 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 191 increasing their positions, 198 reducing their positions, and 80 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
0.26% less ownership
Funds ownership: 94.56% → 94.3% (-0.26%)
4% less repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 198
3% less funds holding
Funds holding: 537 → 522 (-15)
9% less capital invested
Capital invested by funds: $6.75B → $6.15B (-$599M)
15% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 80
29% less call options, than puts
Call options by funds: $3.99M | Put options by funds: $5.61M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$125M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$38.1M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$31.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.9M |
| 5 |
Goldman Sachs
New York
|
+$25.9M |
Top Sellers
CHE Hedge Fund Activity: Q3 2025 in Review
522 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2025, worth a combined $6.15B — down 8.9% from $6.75B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of CHE and 68 opened new positions — a net loss of 12 holders — while 198 trimmed existing stakes and 191 added.
The largest buyer was JP Morgan Chase, adding an estimated $125M. The largest seller was Fidelity Investments, cutting an estimated $46.6M.
- 522 institutional investors held Chemed (CHE) as of Q3 2025, down from 537 in Q2 2025.
- Funds reported $6.15B of Chemed stock for Q3 2025, down 8.9% quarter-over-quarter.
- 68 funds opened new Chemed positions in Q3 2025 and 80 closed out, a net change of -12 holders.
- The largest Chemed buyer in Q3 2025 was JP Morgan Chase, an estimated $125M added.
- The largest Chemed seller in Q3 2025 was Fidelity Investments, an estimated $46.6M sold.
Based on aggregated 13F filings for Q3 2025.